| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$80 |
RC Drilling locates more magnetite at Morrisey
|
29 Jul 2025 8:58AM |
$0.042 |
$0.050 |
risen by
19.05%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- AusQuest Limited reported results from RC drilling at the Morrisey magnetite prospect.
- Drilling intersected significant zones of magnetite mineralization.
- The drilling extended the strike length of known magnetite mineralization.
- Magnetic surveys and drilling results indicate strong exploration potential.
- Further assay results from the drilling are pending.
- The results support the company’s ongoing strategy to develop its iron ore assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$380 |
Update - Notification of buy-back - RG8
|
29 Jul 2025 8:57AM |
$2.050 |
$2.590 |
risen by
26.34%
|
|
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$48 |
Q4 FY25 Investor Presentation
|
29 Jul 2025 8:57AM |
$0.083 |
$0.069 |
fallen by
16.87%
|
|
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$22 |
Notification of cessation of securities - ALV
|
29 Jul 2025 8:56AM |
$0.026 |
$0.090 |
risen by
246.15%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$316 |
Quarterly Activities Report
|
29 Jul 2025 8:56AM |
$0.705 |
$1.325 |
risen by
87.94%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced drilling operations at Tunkillia and Tarcoola Gold Projects.
- Reported positive results from drilling, including high-grade gold intersections.
- Updated Mineral Resource Estimates for Tunkillia and Tarcoola.
- Completed metallurgical testwork supporting project development.
- Engaged in stakeholder and investor communications.
- Maintained strong cash position and financial discipline.
- Outlined next steps including continued drilling, feasibility studies, and resource upgrades.
- Strengthened strategic positioning in South Australia's gold sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$480 |
Update - Notification of buy-back - VG1
|
29 Jul 2025 8:56AM |
$1.750 |
$1.950 |
risen by
11.43%
|
|
| Greatland Resources Limited (GGP) ORDINARY FULLY PAID |
Materials |
$7,099 |
June 2025 Quarter Presentation
|
29 Jul 2025 8:56AM |
$6.890 |
$10.550 |
risen by
53.12%
|
|
GGP - Price-sensitive ASX Announcement
Full Release
Key Points
- Net revenue of $487 million and closing cash balance of $575 million
- Gold and copper production with high recovery rates
- Successful integration of Telfer-Havieron operations
- Progress on the Havieron Feasibility Study with completion expected by December 2025
- Significant advancements in resource drilling and mining operations at Telfer and Havieron
- Highest gold recovery at Telfer since 2010
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greatland Resources Limited (GGP) ORDINARY FULLY PAID |
Materials |
$7,099 |
June 2025 Quarter Presentation
|
29 Jul 2025 8:56AM |
$6.890 |
$10.550 |
risen by
53.12%
|
|
GGP - Price-sensitive ASX Announcement
Full Release
Key Points
- Highest annual gold recovery at Telfer since 2010.
- Successful integration of Telfer-Havieron operations.
- Operating cash flow of $310 million and closing cash of $575 million.
- Completion of SAP implementation for independent operations.
- Significant resource development drilling at Telfer.
- Feasibility study for Havieron targeted for December 2025.
- Full exposure to gold prices with protection via gold put options.
- Future growth plans include extending mine life and increasing production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winsome Resources Limited (WR1) ORDINARY FULLY PAID |
Materials |
$115 |
Termination of Call Option Agreement
|
29 Jul 2025 8:55AM |
$0.175 |
$0.470 |
risen by
168.57%
|
|
WR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Winsome Resources Limited (WR1) has terminated a Call Option Agreement with Lithium Royalty Corp (LRC).
- The agreement was originally signed on 30 June 2023 regarding the possible sale of a 1.5% NSR royalty interest in the Cancet property, Quebec.
- LRC held a call option for the purchase of the royalty interest, but this option has now been terminated.
- Termination of the agreement was mutually agreed by both parties.
- Both WR1 and LRC will have no further rights or obligations under the Call Option Agreement.
- WR1 states the termination will not materially affect its current activities or operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Asara Resources Limited (AS1) ORDINARY FULLY PAID |
Materials |
$160 |
Quarterly Activities and Cashflow Report - June 2025
|
29 Jul 2025 8:55AM |
$0.053 |
$0.100 |
risen by
88.68%
|
|
AS1 - Price-sensitive ASX Announcement
Full Release
Key Points
- The AS1 project saw ongoing exploration and resource definition activities during the June 2025 quarter.
- Technical studies to support future project development and potential feasibility evaluation were advanced.
- Quarterly cashflow reporting indicates responsible cash management and allocation toward exploration and evaluation.
- Corporate updates include stakeholder engagement and updates on company governance.
- Forward-looking priorities include further drilling, technical studies, and permitting processes.
- Asara Resources Limited remains focused on de-risking and advancing the AS1 project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Geopacific Resources Ltd (GPR) ORDINARY FULLY PAID |
Materials |
$106 |
Quarterly Activities Report and 5B Cashflow - June 2025
|
29 Jul 2025 8:54AM |
$0.030 |
$0.033 |
risen by
10%
|
|
GPR - Price-sensitive ASX Announcement
Full Release
Key Points
- Geopacific Resources Ltd focused on the Woodlark Gold Project in Papua New Guinea
- Engaged with potential partners and investors during the quarter
- Progress in project permitting and community engagement
- Early works commenced on project optimisation
- Strict cost controls implemented; cash balance of $3.58 million at end of quarter
- No mining or production activities reported for the period
- Appendix 5B included outlining operating and investing cashflows
- No substantive exploration activities conducted during the quarter
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TALI Digital Limited (TD1) ORDINARY FULLY PAID |
Health Care |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:53AM |
$0.001 |
$0.056 |
risen by
5,500%
|
|
TD1 - Price-sensitive ASX Announcement
Full Release
Key Points
- TALI Digital continued commercialization of TD1, an attention training digital therapeutic.
- Strategic partnerships and pilot studies progressed with organizations in Australia and international markets.
- New agreements signed in the US and India to distribute TALI products in educational and healthcare settings.
- Development milestones reached, including product enhancements and clinical research collaborations.
- Received government grants and R&D tax refund contributing to cash inflows.
- Raised additional capital through a share purchase plan to support operations.
- Quarterly cash flow report details operational and research expenditures.
- Focus on expanding market reach and technology development for broader adoption.
- Engagement with key opinion leaders and clinical partners to support product validation.
- No payments were made to related parties or their associates other than directors’ fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Business progress update, Zimmer Biomet sales units grows 3x
|
29 Jul 2025 8:53AM |
$0.012 |
$0.007 |
fallen by
41.67%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Osteopore Limited (OSX) provided a business progress update focusing on the strong growth of Zimmer Biomet sales units.
- Zimmer Biomet (ZB), a key distributor for OSX, achieved a threefold (3x) increase in sales units of Osteopore products compared to the previous year.
- The significant sales growth reflects increasing clinical acceptance and market penetration of Osteopore’s regenerative implants in key regions.
- The company attributes the sales boost to ZB’s effective sales and distribution efforts, as well as growing surgeon adoption.
- Osteopore’s collaboration with Zimmer Biomet is a critical driver of its commercial expansion, supporting OSX’s broader strategic objectives.
- The update outlines OSX’s ongoing commitment to expanding distribution networks and strengthening partnerships to support continued growth.
- Osteopore continues to invest in product development, clinical evidence, and regulatory approvals to support further market expansion.
- The company’s progress update reiterates a positive business outlook and a focus on delivering value to stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EDU Holdings Limited (EDU) ORDINARY FULLY PAID |
Consumer Discretionary |
$121 |
Market Update - Record First-Half FY25 Results
|
29 Jul 2025 8:53AM |
$0.430 |
$0.840 |
risen by
95.35%
|
|
EDU - Price-sensitive ASX Announcement
Full Release
Key Points
- EDU Holdings Limited recorded strong financial and operational results for the first half of FY25.
- Revenue and EBITDA reached record highs compared to previous periods.
- Student enrolments grew significantly, particularly in health and community services programs.
- Continued strategic investment in course expansion and campus infrastructure.
- Focus on student support, operational efficiency, and geographic diversification.
- Positive outlook maintained for the remainder of the fiscal year.
- Commitment to delivering quality education and supporting student outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aroa Biosurgery Limited (ARX) ORDINARY FULLY PAID |
Health Care |
$242 |
Investor Presentation
|
29 Jul 2025 8:52AM |
$0.580 |
$0.700 |
risen by
20.69%
|
|
| Solis Minerals Ltd (SLM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$11 |
Geophysics Defines Compelling Cu-Au Targets at Cinto
|
29 Jul 2025 8:52AM |
$0.080 |
$0.044 |
fallen by
45%
|
|
SLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Solis Minerals Ltd completed a ground geophysical survey at the Cinto Project in Peru.
- The survey identified strong chargeability and resistivity anomalies, indicating possible sulphide mineralization.
- These anomalies are interpreted as potential copper-gold porphyry targets.
- The geophysical results align with areas of historical artisanal mining and surface geochemical anomalies.
- The defined targets will be tested by drilling to assess their mineralization potential.
- The announcement underscores the technical approach and exploration strategy of Solis Minerals Ltd at Cinto.
- The project highlights the ongoing commitment of Solis Minerals Ltd to copper-gold exploration in Peru.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$48 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:51AM |
$0.083 |
$0.069 |
fallen by
16.87%
|
|
CCA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash receipts from customers totaled $3.3 million, reflecting ongoing revenue growth.
- Change Financial completed its Mastercard principal issuer and acquirer licence, expanding capabilities.
- The company continued to focus on scaling its payments and card solutions offering, especially in Australia and New Zealand.
- New client contracts and technology integration progressed during the quarter.
- Prudent cost management strategies remained in place to support business sustainability.
- The cash flow report includes details of operating, investing, and financing activities.
- Change Financial indicated it has sufficient funding for its future operational needs.
- The report provides a summary of related party transactions for the quarter.
- Ongoing focus on product innovation and business development to drive growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$361 |
Update - Notification of buy-back - PE1
|
29 Jul 2025 8:50AM |
$1.300 |
$1.350 |
risen by
3.85%
|
|
| Aroa Biosurgery Limited (ARX) ORDINARY FULLY PAID |
Health Care |
$242 |
June 2025 Quarterly Report and Appendix 4C
|
29 Jul 2025 8:50AM |
$0.580 |
$0.700 |
risen by
20.69%
|
|
ARX - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash flow report with receipts from customers and operational expenditures
- Updates on strategic initiatives and clinical studies
- Progress in product development and commercial performance
- Business development activities and regulatory updates provided
- Appendix 4C included as per ASX listing requirements
- Emphasis on continued growth and innovation in biosurgery solutions
- Discussion of future outlook and strategic priorities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osmond Resources Limited (OSM) ORDINARY FULLY PAID |
Materials |
$98 |
Osmond Confirms Orion Investigation Permit Award
|
29 Jul 2025 8:50AM |
$0.825 |
$0.770 |
fallen by
6.67%
|
|
OSM - Price-sensitive ASX Announcement
Full Release
Key Points
- Osmond Resources Limited (OSM) has been awarded the Investigation Permit (EL00015) for the Orion Project.
- The Orion Project is located on the Yorke Peninsula in South Australia, approximately 40km west-northwest of Minlaton.
- The permit area covers 1,238 square kilometers and is considered prospective for IOCG and sediment-hosted copper mineralisation.
- The permit was granted by the South Australian Department for Energy and Mining and is valid for five years.
- Osmond plans to conduct exploration activities including geophysical surveys and drilling within the permit area.
- The Orion Project is viewed as strategically important within Osmond's exploration portfolio.
- The company is optimistic about the mineralisation potential within the newly permitted area.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greatland Resources Limited (GGP) ORDINARY FULLY PAID |
Materials |
$7,099 |
June 2025 Quarterly Activities Report
|
29 Jul 2025 8:49AM |
$6.890 |
$10.550 |
risen by
53.12%
|
|
GGP - Price-sensitive ASX Announcement
Full Release
Key Points
- Produced 78,283 oz Au and 3,729t Cu with AISC of $1,736/oz Au.
- Key drill results show promising Au & Cu mineralization at Main Dome and West Dome.
- Sold 87,529 oz Au and 3,740t Cu at A$5,014/oz Au and A$12,718/t Cu.
- Net revenue for the quarter was A$487 million.
- Strong potential for future exploration and mining at key sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Spacetalk Ltd (SPA) ORDINARY FULLY PAID |
Information Technology |
$12 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:48AM |
$0.150 |
$0.110 |
fallen by
26.67%
|
|
SPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities and cash flow for the period ending 31 March 2024.
- Growth in device sales and active subscribers, especially in international markets.
- Operational expenditure reduced as a result of cost-saving measures.
- Continued focus on product development and innovation.
- Expansion of global distribution and retail partnerships, particularly in the UK and Europe.
- Strengthening of brand presence and marketing initiatives.
- Disciplined cash management maintained a stable financial position.
- Plans for upcoming product launches and further market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| One Click Group Limited (1CG) ORDINARY FULLY PAID |
Industrials |
$14 |
One Click Life Surpasses 200,000 Registered Users
|
29 Jul 2025 8:48AM |
$0.009 |
$0.011 |
risen by
22.22%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$38 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:47AM |
$0.145 |
$0.133 |
fallen by
8.62%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities for the period ending 31 March 2024.
- Nova Eye Medical Limited experienced increased sales momentum, particularly in North America.
- The company invested in expanding its direct sales team and clinical support.
- Progress was made with multi-center clinical studies for glaucoma treatment technologies.
- Revenue growth was recorded compared to the previous corresponding period.
- Continued strategic focus on product development and regulatory approvals.
- Cost-saving initiatives were implemented during the period.
- The company maintained a strong cash position at the end of the quarter.
- Detailed Appendix 4C Cash Flow Report provided, including receipts, expenditures, and R&D costs.
- Forecast of cash outflows for the next quarter was included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EDU Holdings Limited (EDU) ORDINARY FULLY PAID |
Consumer Discretionary |
$121 |
ALG T3'25 enrolments - up 2% on PCP
|
29 Jul 2025 8:47AM |
$0.430 |
$0.840 |
risen by
95.35%
|
|
EDU - Price-sensitive ASX Announcement
Full Release
Key Points
- ALG T3'25 enrolments up 2% on the prior corresponding period (PCP)
- Positive enrolment growth demonstrates stability and demand for courses
- EDU Holdings Limited maintains a focus on operational and strategic improvements
- Management reiterates commitment to student recruitment and retention initiatives
- Announcement underscores company’s efforts to support long-term growth
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
